total-news-1024x279-1__1_-removebg-preview.png

SELECT LANGUAGE BELOW

FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza

The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes drug Victoza, paving the way for the launch of another treatment in the country. Hikma's branded generic will compete with Teva Pharmaceuticals' approved generic Victoza, which was launched in the U.S. earlier this year. Authorized generics are exact […]